Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        51-60 of 1460 results for 'vaccine'

        Refine search

        Research

        Strep A: challenges, opportunities, vaccine-based solutions and economics

        Streptococcus pyogenes (Strep A) is a leading cause of morbidity and mortality across the globe, annually causing hundreds of millions of cases of disease. ...

        Research

        Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

        Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including mRNA, adenoviral-vectored, protein subunit and whole-cell inactivated virus vaccines, have now reported efficacy in phase III trials and have received emergency approval in many countries. ...

        Research

        Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with Pneumococcal Conjugate Vaccine

        PPV is immunogenic in 9-month-old children at high risk of pneumococcal infections and does not affect the capacity to produce protective immune responses ...

        News & Events

        Perth trial begins on investigational Golden Staph vaccine

        Perth researchers are calling for volunteers to help test an investigational vaccine against Staphylococcus aureus (golden staph). ...

        News & Events

        Volunteers needed to trial new vaccine against dengue fever

        Perth researchers are about to trial a new vaccine that aims to protect against all four strains of the potentially devastating Dengue Fever. ...

        Research

        Revaccination outcomes of children with vaccine proximate seizures

        Seizures, whether febrile or afebrile, occurring within 14 days following vaccination can be considered as vaccine proximate seizures (VPSs). While the attributable risk and clinical severity of first febrile VPS is well known, the risk and clinical outcomes of VPS recurrence is less well defined. We conducted a retrospective review of revaccination management and outcomes in children who experienced a VPS as their first seizure seen in Australian Specialist Immunisation Clinics between 2013 and 2017. Vaccination outcomes were compared between children who had a VPS as their only seizure (VPS only) and children who had further non-vaccine proximate seizures following their initial VPS (VPS+) prior to review at the clinic. ...

        Research

        SCN1A Variants in vaccine-related febrile seizures: A prospective study

        Pathogenic SCN1A variants may be identified in infants with vaccine-proximate febrile seizures ...

        News & Events

        BCG vaccine does not protect against COVID-19 in healthcare workers

        A world-leading international trial examining the immune boosting benefits of the tuberculosis vaccine, BCG, has found it does not protect healthcare workers against COVID-19. ...

        The Western Australian Influenza Vaccine Effectiveness Study (WAIVE)

        The WAIVE study was conducted over the winter months at Princess Margaret Hospital for 9 years from 2008 to 2015 inclusive. Recruitment has now ...

        Research

        Key steps in our journey to a COVID-19 vaccine program

        Providing a safe and effective coronavirus disease 2019 (COVID‐19) vaccination program is required to mitigate against the current and future negative impacts on the health and wellbeing of all Australians from COVID‐19. An effective vaccination program is a key element required to facilitate economic recovery, safe movement throughout and beyond Australia and a return to the quality of life previously experienced. ...

        Page 6 of 146